Data / Research funding / Tuberous Sclerosis

Tuberous Sclerosis: 97 NIH awards ($90.3M) to 45 organizations

Name: NIH and NSF awards on Tuberous Sclerosis
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

97 NIH awards ($90.3M) in the NIH spending category Tuberous Sclerosis, to 45 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards on Tuberous Sclerosis Watch Tuberous Sclerosis

Topic: NIH spending category

Awards

97 awards in the window.

Award	Agency	Institute or division	Fiscal year	Amount in window	Start	End	Principal investigator	Source
Decoding and Targeting the PI3K-mTOR Signaling Network in Cancer	NIH	National Cancer Institute	2021 to 2025	$4,612,435	August 1, 2022	July 31, 2029	MANNING, BRENDAN D.	reporter.nih.gov
MAP4K3 regulation of cellular stress response pathways in health and disease	NIH	National Institute on Aging	2022 to 2025	$3,333,247	December 1, 2008	August 31, 2027	LA SPADA, ALBERT R	reporter.nih.gov
Cerebellar-Cerebro Cortical Circuits in Social Behaviors	NIH	National Institute of Mental Health	2021 to 2025	$3,075,297	January 1, 2019	February 28, 2029	TSAI, PETER T.	reporter.nih.gov
Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$2,784,762	December 20, 2021	November 30, 2026	KARBOWNICZEK, MAGDALENA	reporter.nih.gov
The Molecular and Genetic Pathogenesis of LAM	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$2,660,652	September 21, 2016	February 28, 2026	HENSKE, ELIZABETH P	reporter.nih.gov
Phosphorylation of TSC2 (S1365) as a novel Regulator of mTORC1 Signaling in T Cells	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$2,551,470	April 8, 2021	March 31, 2026	PEARCE, ERIKA L	reporter.nih.gov
mTORC1 and WNT in lung mesenchyme	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$2,493,165	July 1, 2021	June 30, 2025	KRYMSKAYA, VERA P	reporter.nih.gov
Uterine signaling networks in the pathogenesis of pulmonary lymphangioleiomyomatosis (LAM)	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$2,284,413	July 21, 2020	June 30, 2025	XU, YAN	reporter.nih.gov
TSC Proteins in the Lymphatic Vasculature	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$2,069,522	July 1, 2023	June 30, 2028	YANG, YING	reporter.nih.gov
Molecular Biomarkers in pathogenesis of Lymphangioleiomyomatosis (LAM)	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$2,022,093	September 10, 2023	June 30, 2027	D'ARMIENTO, JEANINE M	reporter.nih.gov
Elucidating the origins of cortical tuber cells using human brain organoid models of TSC	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2025	$1,875,828	May 15, 2016	February 28, 2026	BATEUP, HELEN S.	reporter.nih.gov
Strengths and weaknesses in learning in mice with ASD risk genes	NIH	National Institute of Mental Health	2023 to 2025	$1,842,639	July 1, 2023	April 30, 2028	WILBRECHT, LINDA E	reporter.nih.gov
Genetics of LAM	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$1,809,373	December 15, 2020	November 30, 2025	KWIATKOWSKI, DAVID J.	reporter.nih.gov
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$1,782,554	June 15, 2023	May 31, 2027	LE POOLE, I. CAROLINE	reporter.nih.gov
Elucidating pathogenic mechanisms in STRADA-related brain malformation and epilepsy	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2025	$1,696,274	August 15, 2022	June 30, 2027	DANG, LOUIS TUONG CHINH	reporter.nih.gov
Development of a Multiplex Proteomics Assay for High-Throughput Newborn Screening of a New Set of Treatable Neonatal Diseases	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2023 to 2025	$1,622,765	April 19, 2023	January 31, 2027	HAHN, SIHOUN	reporter.nih.gov
Proteostasis dysregulation and the development of Alzheimer's-like neurodegeneration and dementia in Down syndrome	NIH	National Institute on Aging	2023 to 2025	$1,585,822	December 1, 2022	November 30, 2027	PRATICO, DOMENICO	reporter.nih.gov
Disrupted Ciliary Signaling in the Brain Pathology of Tuberous Sclerosis Complex	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$1,569,617	August 1, 2019	September 10, 2022	SAHIN, MUSTAFA	reporter.nih.gov
Mechanisms of immunosuppression in the development and progression of renal disease in Tuberous Sclerosis Complex	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023 to 2025	$1,569,410	April 5, 2023	March 31, 2028	HENSKE, ELIZABETH P	reporter.nih.gov
Role of TFEB and TFE3 in Tuberous Sclerosis Complex (TSC) Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$1,521,682	September 1, 2022	April 30, 2026	HENSKE, ELIZABETH P	reporter.nih.gov
Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$1,474,086	April 1, 2019	March 31, 2024	TELLIDES, GEORGE	reporter.nih.gov
mTOR signaling in lung homeostasis, aging and disease	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$1,464,620	May 15, 2020	April 30, 2025	KRYMSKAYA, VERA P	reporter.nih.gov
Tuberous Sclerosis Complex Patients iPSC-derived NPCs and NCCs as Human Model Systems to Identify Novel Targets	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$1,460,553	June 15, 2019	May 30, 2025	RAMESH, VIJAYA	reporter.nih.gov
Identifying mTOR Dependent Periods During Brain Development	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2024	$1,451,078	September 1, 2020	August 31, 2024	IHRIE, REBECCA A	reporter.nih.gov
Epilepsy in Focal Cortical Malformations	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$1,450,581	April 1, 2019	March 31, 2024	BORDEY, ANGELIQUE	reporter.nih.gov
Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals	NIH	National Institute of Mental Health	2024 to 2025	$1,430,567	November 8, 2023	October 31, 2028	STUDER, LORENZ P.	reporter.nih.gov
Mechanisms of mTOR-independent axon growth and guidance defects in TSC2 mutant human neurons	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2024	$1,400,852	May 1, 2020	April 30, 2026	GOMEZ, TIMOTHY M	reporter.nih.gov
Role of mTOR in Circadian and Sleep Deregulation in Smith-Kingsmore Syndrome (SKS)	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$1,371,419	February 1, 2023	December 31, 2027	LIU, ANDREW C.	reporter.nih.gov
Regulation and biological functions of mRNA Alternative Polyadenylation in the Brain	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2024	$1,323,784	March 15, 2020	January 31, 2026	HWANG, HUN-WAY	reporter.nih.gov
Role of the Lysosome in the Pathogenesis and Therapy of LAM	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$1,318,383	July 15, 2020	June 30, 2025	HENSKE, ELIZABETH P	reporter.nih.gov
Develop lung-targeted synthetic lipid nanoparticles for mRNA medicine treating pulmonary lymphangioleiomyomatosis	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,305,047	April 15, 2024	February 29, 2028	XU, QIAOBING	reporter.nih.gov
Cortical development and pathogenesis in DEPDC5-related epilepsies	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$1,252,682	September 15, 2019	May 31, 2025	WANG, YU	reporter.nih.gov
Molecular and structural mechanisms of mTORC1 regulation in cancer	NIH	National Cancer Institute	2024 to 2025	$1,168,072	January 1, 2024	December 31, 2028	HURLEY, JAMES H	reporter.nih.gov
Elucidation of Tumor Resistance Mechanisms in Tuberous Sclerosis Complex-Associated Renal Angiomyolipoma for the Design of Novel Nanotherapies	NIH	National Cancer Institute	2023 to 2025	$1,165,239	June 1, 2023	May 31, 2028	LEMOS, DARIO	reporter.nih.gov
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models	NIH	National Center for Advancing Translational Sciences	2021	$1,149,180	July 21, 2017	June 30, 2023	WIKSWO, JOHN PETER	reporter.nih.gov
Identify common mechanisms of neurodegeneration between Alzheimer's disease and Down syndrome	NIH	National Institute on Aging	2021 to 2022	$1,091,979	September 15, 2018	May 31, 2025	VELAZQUEZ, RAMON	reporter.nih.gov
The Circadian Molecular Clock is a Biomarker for Epilepsy in Focal Cortical Dysplasia	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$1,026,246	February 1, 2019	January 31, 2024	LIU, JUDY SHIH-HWA	reporter.nih.gov
Pathogenic Mechanisms of Pulmonary Lymphangioleiomyomatosis	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$988,855	April 1, 2019	September 30, 2022	SHI, WEI	reporter.nih.gov
Examining Sexual Dimorphisms: The Role of Estradiol Signaling in Modulating Immunity	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$938,175	December 1, 2024	June 30, 2025	HAMMES, STEPHEN R.	reporter.nih.gov
Urokinase-type plasminogen activator (uPA) in pathogenesis of lymphangioleiomyomatosis (LAM)	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$909,477	January 1, 2019	December 31, 2024	STEPANOVA, VICTORIA	reporter.nih.gov
Natural Killer Cell Functions in Lymphangioleiomyomatosis	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$799,900	January 1, 2019	December 31, 2023	BORCHERS, MICHAEL	reporter.nih.gov
Early Communication in Tuberous Sclerosis Complex (TSC) and its Prediction of Autism	NIH	National Institute on Deafness and Other Communication Disorders	2022 to 2025	$793,981	August 1, 2022	May 31, 2027	GIPSON, TANJALA TRINETTE	reporter.nih.gov
Molecular Mechanisms of Neuronal Hyperactivity in Tuberous Sclerosis Complex	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2024	$775,776	April 15, 2020	February 28, 2025	WINDEN, KELLEN	reporter.nih.gov
Molecular Mechanism of Hippocampal network excitability in a novel, in vivo model of Tuberous Sclerosis Complex	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$760,121	July 15, 2018	June 30, 2024	RAAB-GRAHAM, KIMBERLY FRANCES	reporter.nih.gov
Mechanisms of focal epileptogenesis in mTORopathies	NIH	National Institute of Neurological Disorders and Stroke	2025	$743,776	September 11, 2025	August 31, 2033	DANZER, STEVE C	reporter.nih.gov
Cellular determinants of responsiveness to mTOR inhibitors in LAM	NIH	National Heart, Lung, and Blood Institute	2025	$739,236	February 1, 2025	November 30, 2028	XU, YAN	reporter.nih.gov
Mechanisms of Change with Early Intervention in Tuberous Sclerosis Complex	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021 to 2022	$730,479	July 1, 2017	March 31, 2023	JESTE, SHAFALI SPURLING	reporter.nih.gov
Dysregulation of sphingolipid metabolism and signaling in LAM	NIH	National Heart, Lung, and Blood Institute	2025	$728,776	September 3, 2025	May 31, 2029	YU, JANE	reporter.nih.gov
The role of oxidative stress and inflammation in epileptogenesis	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$704,376	May 15, 2018	March 31, 2025	TALOS, DELIA	reporter.nih.gov
Regulation of Lipid Catabolism by Autophagy in Neural Stem Cell of Tuberous Sclerosis Complex	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$702,188	July 15, 2018	June 30, 2024	WANG, CHENRAN	reporter.nih.gov
Leveraging genetically-encoded heterogeneity to understand TANDs and seizures in novel models of TSC	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$679,503	February 16, 2024	November 30, 2028	HERNAN, AMANDA	reporter.nih.gov
Synaptic changes and hypersynchronous network activity in mTORopathies	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$679,278	February 1, 2019	August 15, 2022	WESTON, MATTHEW C	reporter.nih.gov
The impact of Tsc-mTOR signaling on basal ganglia function	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$642,235	April 15, 2019	March 31, 2024	BATEUP, HELEN S.	reporter.nih.gov
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED)-CCC	NIH	National Heart, Lung, and Blood Institute	2021	$536,596	September 20, 2016	June 30, 2025	MCCORMACK, FRANCIS XAVIER	reporter.nih.gov
Optimization and mechanisms of electrical neurostimulation in mouse models of epilepsy	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$465,962	December 1, 2023	November 30, 2028	FOUTZ, THOMAS	reporter.nih.gov
Filamin A in TSC and FCDII	NIH	National Institute of Neurological Disorders and Stroke	2025	$461,250	May 23, 2025	April 30, 2027	BORDEY, ANGELIQUE	reporter.nih.gov
Dissecting the Role of Translation Mechanisms Downstream of mTORC1 in TSC Neuropathogenesis	NIH	National Institute of Neurological Disorders and Stroke	2021	$460,628	April 1, 2021	September 30, 2022	THOREEN, CARSON CORNELL	reporter.nih.gov
Menstrual Cycle-Related Symptom Variability as a Prognostic Indicator in Lymphangioleiomyomatosis	NIH	National Center for Advancing Translational Sciences	2022 to 2023	$445,500	August 1, 2022	July 31, 2025	GUPTA, NISHANT	reporter.nih.gov
Neurodevelopmental Function of TBC1D7: A Core Component of the TSC Complex	NIH	National Institute of Neurological Disorders and Stroke	2022	$438,625	September 15, 2022	August 31, 2024	MANNING, BRENDAN D.	reporter.nih.gov
Lipid homeostasis and mitochondrial fitness in LAM pathogenesis and therapy	NIH	National Heart, Lung, and Blood Institute	2023	$434,868	September 23, 2023	August 31, 2025	PRIOLO, CARMEN	reporter.nih.gov
KCC2 and epilepsy in a mouse model of tuberous sclerosis complex	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$427,625	April 1, 2024	March 31, 2027	WONG, MICHAEL	reporter.nih.gov
Gene therapy for Tuberous Sclerosis	NIH	National Institute of Neurological Disorders and Stroke	2022	$420,000	August 1, 2019	July 31, 2024	BREAKEFIELD, XANDRA OWENS	reporter.nih.gov
Evaluating dendritic DJ-1 targets as a framework for identifying pharmacotherapies for TSC-related neurological disorders	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$418,140	May 20, 2023	April 30, 2027	NIERE, FARR	reporter.nih.gov
The Role of DEPDC5 in Epileptogenesis and Brain Malformations	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$413,086	July 1, 2019	June 26, 2023	YUSKAITIS, CHRISTOPHER JOSEPH	reporter.nih.gov
Molecular mechanisms of abnormal dendritic spine development and function in human neurons with TSC2 disease mutations	NIH	National Institute of Neurological Disorders and Stroke	2021	$407,645	September 20, 2021	February 29, 2024	GOMEZ, TIMOTHY M	reporter.nih.gov
Therapeutic potential of targeting DNA repair deficiency in TSC	NIH	National Cancer Institute	2021 to 2022	$398,743	July 1, 2021	June 30, 2024	MACKEIGAN, JEFFREY PAUL	reporter.nih.gov
TSC2 Signaling in Pulmonary Arterial Hypertension	NIH	National Heart, Lung, and Blood Institute	2021	$397,063	September 1, 2012	March 31, 2023	GONCHAROVA, ELENA	reporter.nih.gov
Characterizing genetic modifiers in tumor burden of Tuberous Sclerosis Complex	NIH	National Cancer Institute	2021 to 2024	$373,592	March 1, 2021	November 27, 2024	VAUGHAN, ROBERT MARK	reporter.nih.gov
Tsc1 Regulation of Purkinje Neuron Firing and Cerebellar Function	NIH	National Institute of Neurological Disorders and Stroke	2022	$361,250	January 1, 2022	December 31, 2025	RANSDELL, JOSEPH L.	reporter.nih.gov
The Role of STRADA in Epileptogenesis and Brain Malformations	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$354,844	September 1, 2018	February 14, 2024	DANG, LOUIS TUONG CHINH	reporter.nih.gov
Synaptic changes and hypersynchronous network activity in mTORopathies	NIH	National Institute of Neurological Disorders and Stroke	2023	$342,345	February 1, 2019	January 31, 2025	WESTON, MATTHEW C	reporter.nih.gov
Role of mTOR Hyperactivation in Pulmonary Vascular Remodeling	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$329,400	August 15, 2024	July 31, 2029	LIN, SUSAN M	reporter.nih.gov
miRNA-Nanotechnology as a novel regenerative therapy for lymphangioleiomyomatosis	NIH	National Human Genome Research Institute	2023	$301,016	September 25, 2023	August 31, 2025	PLEIMES, DIRK	reporter.nih.gov
Novel Combination Therapy for Treatment and Prevention of PulmonaryLymphangioleiomyomatosis (LAM) and Tuberous Sclerosis Complex (TSC)	NIH	National Heart, Lung, and Blood Institute	2023	$299,997	September 1, 2023	August 31, 2025	PLEIMES, DIRK	reporter.nih.gov
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED) - DCC	NIH	National Heart, Lung, and Blood Institute	2021	$291,401	September 20, 2016	June 30, 2024	KRISCHER, JEFFREY P	reporter.nih.gov
Patient centered outcome measures and prediction tools in lymphangioleiomyomatosis	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$274,072	January 1, 2024	December 31, 2026	GUPTA, NISHANT	reporter.nih.gov
Nitazoxanide as a Novel Therapy for Rare Disease Lymphangioleiomyomatosis and Tuberous Sclerosis	NIH	National Heart, Lung, and Blood Institute	2021	$256,400	April 10, 2021	December 31, 2023	PLEIMES, DIRK	reporter.nih.gov
TSC1 in Alveolar Macrophages Development and Function	NIH	National Institute of Allergy and Infectious Diseases	2021	$241,500	April 8, 2020	March 31, 2023	ZHONG, XIAOPING	reporter.nih.gov
Mechanisms of change with early intervention in Tuberous Sclerosis Complex	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$195,116	July 1, 2017	June 30, 2021	JESTE, SHAFALI SPURLING	reporter.nih.gov
Impact of mitochondrial dynamics on the development of renal cysts in Tuberous Sclerosis Complex (TSC)	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$155,959	September 15, 2018	July 18, 2022	LAM, HILAIRE COLLETTA	reporter.nih.gov
Metabolically Reprogramming Hepatic Macrophages to Conquer Immune Desert Tumors	NIH	National Cancer Institute	2025	$145,336	March 1, 2025	February 28, 2027	JI, LIANGLIANG	reporter.nih.gov
Double Duty: Elucidating the Effects of Estrogen on Tumor Cells and their Microenvironment in Lymphangioleiomyomatosis	NIH	National Cancer Institute	2021 to 2023	$140,482	September 1, 2020	August 31, 2024	MINOR, BRIAUNNA MONET NYIKA	reporter.nih.gov
Polo-like kinase 1 and sphingosine-1-phosphate circuitry enhances TSC-mutant cell survival	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023	$99,999	September 20, 2023	September 19, 2024	YU, JANE	reporter.nih.gov
mTOR Hyperactivity Disrupts the Molecular Framework of Inhibitory Synapses	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$92,788	June 4, 2021	June 3, 2023	BARTH, SAMUEL HENRY	reporter.nih.gov
Role of mTORC1 dependent translation in neurological deficits of TSC	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2023	$83,096	July 1, 2022	August 31, 2023	BINDER, MATTHEW	reporter.nih.gov
Defining Mechanisms of Dynamic mTORC1 Regulation in the Liver with Fasting and Feeding	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2023	$71,497	July 1, 2022	June 23, 2025	KALAFUT, KRYSTLE	reporter.nih.gov
Mapping the Time Course of mTORC1-Driven Tumorigenesis in the Developing Brain	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$67,298	July 28, 2022	August 31, 2024	GEBEN, LAURA CATHERINE	reporter.nih.gov
Neuronal Primary Cilia Dysfunction in Tuberous Sclerosis Complex	NIH	National Institute of Neurological Disorders and Stroke	2025	$45,696	January 3, 2025	January 2, 2028	DONOVAN, KATHLEEN	reporter.nih.gov
Regulation of the cell cycle and growth signaling pathways by a sensing mechanism for Vitamin B5-Coenzyme A metabolism	NIH	National Cancer Institute	2021 to 2022	$44,154	September 1, 2020	October 31, 2022	BARRITT, SAMUEL	reporter.nih.gov
Regulation of Epileptogenesis by Hippocampal Somatostatin Interneurons in a Model of mTORopathies	NIH	National Institute of Neurological Disorders and Stroke	2024	$42,574	July 15, 2024	June 30, 2026	DRAKE, AUSTIN	reporter.nih.gov
2022 International Lymphangioleiomyomatosis (LAM) Research Conference	NIH	National Heart, Lung, and Blood Institute	2022	$40,000	July 10, 2022	June 30, 2023	GUPTA, NISHANT	reporter.nih.gov
The role of TGF-β signaling in cell-cell interactions in the pathogenesis of lymphangioleiomyomatosis	NIH	National Heart, Lung, and Blood Institute	2025	$39,140	September 1, 2025	August 31, 2028	LIU, EMILY CHI	reporter.nih.gov
2023 International TSC Research Conference	NIH	National Institute of Neurological Disorders and Stroke	2023	$35,486	September 1, 2023	August 31, 2024	ROBERDS, STEVEN L	reporter.nih.gov
The 2025 LAM Foundation International Lymphangioleiomyomatosis Research Conference	NIH	National Heart, Lung, and Blood Institute	2025	$30,000	September 5, 2025	August 31, 2026	KRYMSKAYA, VERA P	reporter.nih.gov
2025 International TSC Research Conference	NIH	National Institute of Neurological Disorders and Stroke	2025	$25,000	June 20, 2025	May 31, 2026	ROBERDS, STEVEN L	reporter.nih.gov
Pulmonary Endothelial-Mesenchymal Crosstalk in Hyperactive mTOR Lung Diseases	NIH	National Heart, Lung, and Blood Institute	2022	$24,957	January 1, 2022	April 30, 2022	LIN, SUSAN M	reporter.nih.gov
Defining the Biochemical Functions of the TSC Tumor Suppressors in mTORC1 Signaling	NIH	National Cancer Institute	2021	$2,500	May 1, 2021	September 29, 2021	EVARTS, SOPHIE MORGAN	reporter.nih.gov

Organizations

Organization	Place	NIH awards	NIH amount	NSF amount
Brigham and Women's Hospital	Boston, MA	8	$10.6 million	$0
University of Pennsylvania	Philadelphia, PA	7	$6 million	$0
University of California-Berkeley	Berkeley, CA	4	$5.5 million	$0
Harvard University D/b/a Harvard School of Public Health	Boston, MA	4	$5.1 million	$0
Yale University	New Haven, CT	5	$3.9 million	$0
Cincinnati Childrens Hosp Med CTR	Cincinnati, OH	4	$3.8 million	$0
University of Cincinnati	Cincinnati, OH	8	$3.6 million	$0
University of California-Irvine	Irvine, CA	1	$3.3 million	$0
University of Michigan at Ann Arbor	Ann Arbor, MI	3	$3.3 million	$0
Ut Southwestern Medical Center	Dallas, TX	1	$3.1 million	$0
Boston Children's Hospital	Boston, MA	4	$2.8 million	$0
Texas Tech University Health Scis Center	Lubbock, TX	1	$2.8 million	$0
Vanderbilt University	Nashville, TN	3	$2.7 million	$0
Johns Hopkins University	Baltimore, MD	1	$2.6 million	$0
University of South Florida	Tampa, FL	2	$2.4 million	$0
Columbia University Health Sciences	New York, NY	1	$2 million	$0
Massachusetts General Hospital	Boston, MA	2	$1.9 million	$0
University of Wisconsin-Madison	Madison, WI	2	$1.8 million	$0
Northwestern University at Chicago	Chicago, IL	1	$1.8 million	$0
Children's Hospital of Los Angeles	Los Angeles, CA	2	$1.7 million	$0
Seattle Children's Hospital	Seattle, WA	1	$1.6 million	$0
Temple Univ of the Commonwealth	Philadelphia, PA	1	$1.6 million	$0
Sloan-Kettering Inst Can Research	New York, NY	2	$1.6 million	$0
University of Florida	Gainesville, FL	1	$1.4 million	$0
University of Pittsburgh at Pittsburgh	Pittsburgh, PA	1	$1.3 million	$0
Tufts University	Medford, MA	1	$1.3 million	$0
Arizona State University	Scottsdale, AZ	1	$1.1 million	$0
University of Rochester	Rochester, NY	2	$1.1 million	$0
Brown University	Providence, RI	1	$1 million	$0
Washington University	Saint Louis, MO	2	$893,587	$0
Biosputnik LLC	New York, NY	3	$857,413	$0
Wake Forest University Health Sciences	Winston-Salem, NC	2	$852,909	$0
University of Tennessee Health Sci CTR	Memphis, TN	1	$793,981	$0
Michigan State University	East Lansing, MI	2	$772,335	$0
Nemours Children's Hospital, Delaware	Wilmington, DE	1	$679,503	$0
University of Vermont & ST Agric College	Burlington, VT	1	$679,278	$0
North Carolina Agricultural & Technical State University	Greensboro, NC	1	$418,140	$0
University of California at Davis	Davis, CA	1	$397,063	$0
Miami University	Oxford, OH	1	$361,250	$0
Virginia Polytechnic Institute and State University	Blacksburg, VA	1	$342,345	$0
Duke University	Durham, NC	1	$241,500	$0
University of California Los Angeles	Los Angeles, CA	1	$195,116	$0
Tuberous Sclerosis Alliance	Silver Spring, MD	2	$60,486	$0
Harvard Medical School	Boston, MA	1	$44,154	$0
University of Iowa	Iowa City, IA	1	$39,140	$0

Funding by fiscal year

Fiscal year	NIH awards	NIH amount	NSF amount
2025	37	$16,890,224	$0
2024	36	$15,806,910	$0
2023	43	$17,319,635	$0
2022	51	$20,633,016	$0
2021	49	$19,666,361	$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunity	Number	Agency	Listing	Closes	Award ceiling	Why it matches
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)	PA-25-080	NIH		September 7, 2027	Not listed	Notice number printed on 1 award here
Functional Target Validation for Alzheimer's Disease-Related Dementias	RFA-NS-26-034	NIH	93.853	November 6, 2026	Not listed	Same assistance listing 93.853 as 38 awards here
Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)	PAR-27-007	NIH	93.853	November 10, 2026	Not listed	Same assistance listing 93.853 as 38 awards here
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)	RFA-NS-26-001	NIH	93.853	November 10, 2026	Not listed	Same assistance listing 93.853 as 38 awards here
Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)	RFA-NS-26-030	NIH	93.853	November 10, 2026	Not listed	Same assistance listing 93.853 as 38 awards here
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)	PAR-25-369	NIH	93.853	November 18, 2026	Not listed	Same assistance listing 93.853 as 38 awards here
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)	PAR-25-371	NIH	93.853	November 18, 2026	Not listed	Same assistance listing 93.853 as 38 awards here
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)	PAR-25-052	NIH	93.853	November 19, 2026	Not listed	Same assistance listing 93.853 as 38 awards here
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)	RFA-AT-25-003	NIH	93.853	November 23, 2026	$375,000	Same assistance listing 93.853 as 38 awards here
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)	RFA-OD-27-008	NIH	93.853	December 2, 2026	Not listed	Same assistance listing 93.853 as 38 awards here
Emerging Global Leader Award (K43 Independent Clinical Trial Required)	PAR-24-295	NIH	93.853	December 3, 2026	Not listed	Same assistance listing 93.853 as 38 awards here
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)	PAR-24-296	NIH	93.853	December 3, 2026	Not listed	Same assistance listing 93.853 as 38 awards here
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)	RFA-OD-24-011	NIH	93.853	December 4, 2026	Not listed	Same assistance listing 93.853 as 38 awards here
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)	PAR-24-214	NIH	93.853	January 7, 2027	$375,000	Same assistance listing 93.853 as 38 awards here
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)	RFA-NS-25-023	NIH	93.853	January 15, 2027	$350,000	Same assistance listing 93.853 as 38 awards here
HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)	RFA-DA-28-011	NIH	93.853	January 26, 2027	Not listed	Same assistance listing 93.853 as 38 awards here
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)	RFA-DA-28-012	NIH	93.853	January 26, 2027	Not listed	Same assistance listing 93.853 as 38 awards here
Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)	PAR-24-268	NIH	93.853	January 27, 2027	$500,000	Same assistance listing 93.853 as 38 awards here
Translational Neural Devices (R61/R33 - Clinical Trial Optional)	PAR-25-053	NIH	93.853	January 28, 2027	Not listed	Same assistance listing 93.853 as 38 awards here
BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)	RFA-NS-24-031	NIH	93.853	January 28, 2027	$750,000	Same assistance listing 93.853 as 38 awards here

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.